Key takeaways

  • Oophorectomy removes the ovaries; it is a separate decision from hysterectomy, which removes the uterus. Removing both ovaries before menopause triggers surgical menopause immediately.
  • For average-risk premenopausal women (especially under 50) having benign surgery, keeping healthy ovaries is usually the more health-protective choice.
  • Clear indications to remove ovaries include ovarian cancer or a suspicious mass, BRCA1/BRCA2 risk-reducing surgery, a non-viable torsed ovary, severe infection, or refractory ovarian endometriosis.
  • Opportunistic salpingectomy (removing only the tubes, keeping the ovaries) is a middle path that lowers future ovarian cancer risk for many average-risk women without causing menopause.
  • After premenopausal removal of both ovaries, hormone replacement therapy (HRT) until about age 50 is usually essential, not optional, unless there is a contraindication such as oestrogen-sensitive breast cancer.
  • Ask before surgery: why is the ovary coming out, one or both, could the plan change during surgery, and what is the menopause plan afterwards?

What an Oophorectomy Actually Is

An oophorectomy removes one or both ovaries. The terms matter, because consent forms and discharge summaries in Indian hospitals often abbreviate them:

  • Unilateral oophorectomy removes one ovary, usually for a cyst, tumour, ovarian torsion, or damage that cannot be managed conservatively. The remaining ovary keeps making hormones.
  • Bilateral oophorectomy removes both ovaries. Hormone production stops.
  • Bilateral salpingo-oophorectomy (BSO) removes both ovaries and both fallopian tubes together.

The surgery may be done by laparoscopy, robotically, or through an open abdominal incision. In benign disease, laparoscopy is common in larger Indian centres because recovery is faster. In cancer surgery, oophorectomy is usually part of a larger staging operation with hysterectomy, biopsies, and peritoneal washings.

What matters most to you is the hormonal consequence, not the incision. The ovaries make oestrogen, progesterone, and androgens that drive menstrual cycling, bone metabolism, heart health, sexual function, and overall hormonal stability. The fallopian tubes do not. Keeping one ovary usually preserves hormone production; losing both ends it.

A woman can sign a consent form, hear only that she had "uterus surgery," and later discover her ovaries and tubes were also removed. That is a counselling failure, not an unavoidable complexity of medicine. You are entitled to know exactly which organs are being removed and why.

When Oophorectomy Is Genuinely Needed

There are clear, evidence-based reasons to remove ovaries. The strongest is ovarian cancer or a strongly suspicious ovarian mass. Ovarian cancer is one of the more common cancers in Indian women and often presents late because early symptoms are vague. A complex mass with solid areas, papillary projections, ascites, a raised CA-125, or MRI features concerning for malignancy should not be approached casually. These patients are best referred to a gynaecologic oncologist or a tertiary centre (AIIMS, Tata Memorial, Kidwai, JIPMER, or a regional cancer centre) where tumour-board review and proper staging are available.

A second major indication is hereditary cancer prevention in women carrying BRCA1 or BRCA2 mutations. Risk-reducing BSO meaningfully lowers future ovarian, fallopian tube, and peritoneal cancer risk, and in premenopausal carriers also lowers breast cancer risk. If your family has a strong pattern of breast or ovarian cancer, BRCA testing and genetic counselling come first.

There are also urgent and benign indications where removal can be the safest course:

Decision-Making in Premenopausal Women

For premenopausal women, especially those under 50, the default in benign surgery is usually ovary preservation even when the uterus is being removed. Healthy ovaries are not redundant after childbearing. They keep producing oestrogen and androgens that support sleep, bone density, vascular health, vaginal tissue, libido, and quality of life. Removing them at 36, 42, or 47 is not the same as reaching menopause gradually at 50 or 51 — the body loses hormones abruptly, and that abruptness is what makes surgical menopause harder for many women.

This is where Indian consultations still fall short. Women hear phrases like "once the family is complete, remove everything" or "after forty the ovaries are useless." Both are medically poor shortcuts. A woman having benign hysterectomy for Uterine Fibroids in India: Symptoms, Treatment, Cost & Fertility may assume ovary removal is the "thorough" option, and relatives may push for a one-time definitive procedure because repeat hospitalisation is hard. But if cancer risk is average and the ovaries are normal, keeping them is usually the more health-protective choice.

The strongest reasons to preserve ovaries are long-term. Early bilateral removal is linked to more severe hot flashes, faster bone loss and osteoporosis, worse urogenital symptoms, and higher cardiovascular risk unless hormone therapy is used. Some women also report concentration problems, low desire, and mood changes that disrupt work and family life — particularly heavy for Indian women still carrying caregiving and household responsibilities in their forties.

A good consent discussion asks four questions: what is the risk if we keep the ovaries, what is the risk if we remove them, will hormone therapy be appropriate afterwards, and how will this affect the next ten to fifteen years of health? When women hear those questions clearly, many realise that keeping normal ovaries is not avoidance or incompleteness — it is often the medically stronger decision.

What Surgical Menopause Can Do to the Body

Surgical menopause begins the day both ovaries stop working — usually immediately after bilateral oophorectomy. Unlike natural perimenopause, which unfolds over years of fluctuating hormones, this transition is abrupt. Many women develop hot flashes, night sweats, palpitations, insomnia, irritability, and anxiety, and feel as though their body changed overnight. Disrupted sleep alone can become a major problem, worsening mood, concentration, and pain tolerance.

The effects go beyond what is felt in the first month:

  • Bones: Oestrogen withdrawal speeds up bone turnover, so density can fall faster than in natural menopause. This matters in India, where vitamin D deficiency is widespread and bone-density testing is often delayed.
  • Vaginal and urinary tissues: These become thinner and drier, leading to burning, recurrent urinary symptoms, and pain with sex — the genitourinary syndrome of menopause.
  • Heart and brain: Early oestrogen loss without appropriate hormone therapy is associated with higher cardiovascular risk, and there is concern about cognitive effects when ovaries are removed very young. The exact risk depends on age and whether HRT is used. The practical point: early oestrogen loss is not benign, and BSO should not be presented as a neutral add-on in a 38-year-old.
  • Sexual health: Reduced lubrication, lower desire, and pain from dryness are common. Most women improve with HRT, vaginal oestrogen, lubricants, and pelvic-floor care — but only if these are anticipated and planned, not discovered in distress after discharge.

Mood changes deserve separate mention because they are too often dismissed as a personality problem. Family members may say, "you asked for the surgery, why are you like this now?" — turning a physiological transition into a blame narrative. The correct response is clinical: evaluate hormones, sleep, pain, and emotional wellbeing together. Surgical menopause is a health transition that needs active management, not a one-time post-operative inconvenience.

Why HRT Is Usually Essential After Premenopausal Removal

For a premenopausal woman who has both ovaries removed, hormone replacement therapy is usually not an optional comfort measure — it is a core part of protecting health until the natural age of menopause (around 50 to 51). The goal is to replace enough oestrogen to ease hot flashes, improve sleep and mood, protect bones and the heart, and reduce urogenital symptoms during the years the ovaries would normally have been working.

The risk conversation for a 39-year-old who lost both ovaries is completely different from a 59-year-old starting hormones long after natural menopause. Families often mix these up and assume all HRT is the same. It is not.

The regimen depends on whether the uterus is present:

Opportunistic Salpingectomy: A Middle Path Worth Knowing

Opportunistic salpingectomy means removing the fallopian tubes during surgery already being done for another reason, while keeping the ovaries. It has become important because many high-grade serous cancers once labelled "ovarian" are now thought to begin in the distal fallopian tube. If the tubes carry much of the preventable risk and the ovaries are hormonally valuable, removing only the tubes can be a better balance for average-risk women than removing healthy ovaries.

The potential benefit is meaningful. Removing the tubes is often discussed as reducing future ovarian cancer risk, though it does not eliminate risk and should not be oversold as equivalent to BRCA risk-reducing BSO. Its appeal is what it preserves: natural ovarian hormones. A 42-year-old having hysterectomy for fibroids may be able to remove the uterus and tubes, keep both ovaries, avoid immediate menopause, and still lower some future risk.

In India, adoption is uneven. In tertiary minimally invasive units the concept is familiar; in smaller centres, some surgeons either keep the tubes out of habit or remove ovaries too readily because salpingectomy alone was never offered. You do not need to master the literature — you need one practical question for your surgeon: if my ovaries are healthy and I am average risk, can the tubes be removed while keeping the ovaries?

Salpingectomy is not for everyone. It does not replace risk-reducing BSO in BRCA carriers, and it does not treat endometriomas, ovarian tumours, or a torsed necrotic ovary. But for a very large group of Indian women having benign pelvic surgery, it aligns prevention with hormone preservation — and it should be told honestly: ovarian cancer risk is reduced, not erased.

BRCA Timing: When Preventive BSO Is Worth the Trade

Risk-reducing BSO is one of the most effective preventive surgeries in hereditary cancer, but timing matters and is guided by your mutation:

  • BRCA1 carriers: ovarian and tubal cancer risk rises earlier, so surgery is generally advised around age 35 to 40 once childbearing is complete.
  • BRCA2 carriers: risk tends to rise later, so the usual target window is around 40 to 45.

These age bands are not arbitrary. They preserve reproductive opportunity and some hormonal time while still intervening before the cancer-risk curve climbs sharply. Preventive BSO substantially reduces ovarian, tubal, and peritoneal cancer risk (though not to zero, because primary peritoneal cancer can rarely still occur), and in premenopausal carriers also lowers breast cancer risk.

In India this decision is rarely purely medical. It intersects with late marriage, delayed childbearing, IVF planning, family pressure, and cost. Some women discover a mutation only after a sister or mother is diagnosed with breast cancer. Good counselling should include fertility-preservation referrals where appropriate and a clear explanation that BRCA timing is linked to risk biology, not moral urgency or fear.

A preventive BSO should sit inside a structured pathway: genetic counselling, confirmation of childbearing plans, HRT discussion if premenopausal, careful tubal pathology examination, and long-term menopause follow-up. If your mutation status is unknown, start with BRCA testing in India. Waiting for symptoms is exactly what high-risk management tries to avoid — normal scans cannot replace properly timed preventive surgery in a mutation carrier.

Pre-Operative Workup and Planning in India

Good oophorectomy decisions begin before the operating room. If the indication is a cyst or suspected tumour, imaging is central. Pelvic ultrasound is usually first; MRI follows when the mass is indeterminate, large, or concerning. CA-125 is often part of the workup for an adnexal mass, but it is not a screening test for the general population and can also rise in endometriosis, fibroids, adenomyosis, tuberculosis, and inflammation. In India, CA-125 commonly costs around Rs 400 to Rs 1,500 depending on the lab and city. HE4, ROMA scoring, or markers such as AFP, beta-hCG, and LDH may be added in selected younger women when germ-cell tumours are in the differential.

When malignancy is suspected, the patient should not drift into routine benign surgery. A tumour board or at least gynaecologic-oncology review is preferable, because the first surgery matters — inadequate staging or cyst rupture can compromise outcomes. A scan in a smaller town showing a 12 cm complex adnexal mass should trigger referral, not improvisation.

Routine preparation also matters:

Recovery, Adaptation, and Common Complications

Physical recovery depends on the approach. Laparoscopic cases often mean one to two days in hospital, early walking, mild-to-moderate pain, and a two- to four-week return to lighter work. Open abdominal surgery is slower, often four to six weeks or more. Familiar post-operative concerns include wound infection, bleeding, urinary symptoms, bowel sluggishness, fever, and clot risk — all of which should be explained clearly, especially for patients travelling from smaller towns.

What makes recovery after bilateral oophorectomy different is endocrine adaptation. A woman may physically heal while simultaneously entering severe hot flashes, disturbed sleep, mood swings, dryness, and sudden fatigue. Families see small incisions and expect quick normalcy, while the patient feels physiologically destabilised. Naming surgical menopause early helps everyone understand these symptoms are part of recovery, not a failure of attitude.

Sexual and relationship concerns are common and should be normalised. Reduced libido, dryness, and pain are frequent, particularly when no HRT plan exists; vaginal moisturisers, lubricants, and local vaginal oestrogen help many women, and sex after menopause can remain comfortable and pleasurable with the right support. Counselling is useful when surgery was emotionally loaded, as in preventive BRCA surgery or when ovaries were removed unexpectedly during a hysterectomy. Grief over fertility loss is a legitimate reaction, not a secondary detail.

Longer-term follow-up should include more than a wound check — bone health, vitamin D, calcium, exercise, sleep, mood, and cardiovascular risk all deserve review after premenopausal BSO. Recovery here is surgery plus an endocrine transition, and both need follow-up. Support at home makes a measurable difference: in households where women return to cooking, caregiving, and work too soon, recovery becomes physically slower and emotionally harsher. Setting family expectations before discharge is often as important as prescribing the right medicines.

Costs, Access, and Where Indian Women Get This Surgery

In India, oophorectomy is often not billed as a standalone decision because it usually happens alongside hysterectomy, myomectomy, endometriosis surgery, or cancer staging — which makes price transparency poor. A standalone laparoscopic BSO for benign disease may roughly range from about Rs 40,000 to Rs 2 lakh depending on city, hospital, room category, and complexity. Corporate hospitals (Apollo, Fortis, Manipal, Max, Aster) often quote broad packages that may exclude pathology, ICU backup, prolonged stay, or extra consumables. Ask for an itemised estimate, not a headline number.

Public and teaching institutions remain essential, especially for cancer and complex referrals. AIIMS, JIPMER, PGI, regional cancer centres, Kidwai, and Tata Memorial may offer surgery at heavily subsidised rates or effectively free for eligible patients — though waiting time, travel, and crowding can be significant. For a woman from a district town, access is not only whether the surgery exists, but whether she can afford travel, an attendant's stay, time off work, and follow-up visits. That hidden logistical cost is one reason many families accept local surgery even when referral would offer better counselling.

Access has two parts: surgical access and follow-up access. A surgeon may competently remove ovaries but never start or coordinate HRT, leaving the patient to navigate symptoms later. Budget for what comes after surgery too — pathology review, HRT or non-hormonal medicines, lubricants or vaginal therapies, blood tests, and occasional bone-density scans.

A second opinion is often worth the money when ovary removal is proposed in a premenopausal woman for a benign indication. The question is not whether the first surgeon is careless — it is whether another specialist might preserve an ovary, recommend salpingectomy instead of BSO, or refer to a gynaecologic oncologist before an inadequately planned mass surgery. The financially sensible choice is rarely the cheapest immediate package; it is the pathway that avoids avoidable menopause, repeat surgery, or cancer mismanagement.

When to See a Doctor

See a gynaecologist promptly if you have any of the following — and use them as red flags whether or not surgery has been discussed:

Common Myths About Ovary Removal, Corrected

Myth: Oophorectomy is automatic whenever a hysterectomy is done

  • Hysterectomy removes the uterus; oophorectomy removes the ovaries. They are separate decisions. In average-risk premenopausal women having benign hysterectomy, preserving normal ovaries is often preferred because it avoids sudden oestrogen loss.
  • Removing both ovaries during benign hysterectomy may reduce future ovarian pathology, but it causes surgical menopause immediately if you have not yet reached natural menopause. That trade only makes sense with a clear reason such as cancer, BRCA prevention, or severe ovarian disease.
  • For many average-risk women, the more evidence-aligned preventive option is opportunistic salpingectomy, which removes the tubes but preserves ovarian hormones.

Myth: The main effect of bilateral oophorectomy is weight gain

  • Weight can change after any major surgery or menopause transition, but it is not the main medical issue. The immediate concerns after premenopausal BSO are hot flashes, sleep disruption, mood symptoms, vaginal dryness, and rapid oestrogen withdrawal.
  • The long-term impact matters more than the scale: bone loss accelerates, cardiovascular risk rises without appropriate oestrogen, and some women have cognitive and sexual effects far more disruptive than modest weight change.
  • Focusing only on weight trivialises the surgery and can delay proper HRT, bone-health planning, and symptom treatment.

Myth: HRT after BSO is never safe

  • For most women having premenopausal BSO without a contraindication such as oestrogen-receptor-positive breast cancer, HRT is often strongly recommended until about the natural menopause age to protect bones, the heart, sleep, and quality of life.
  • The risk conversation in a 39-year-old who lost both ovaries is different from a 59-year-old starting hormones long after natural menopause. These scenarios are not the same.
  • If the uterus is present, oestrogen usually needs a progestogen partner; if absent, oestrogen alone is often used. This tailored prescribing is standard good practice and should be planned before surgery.

Myth: Indian women are too old or too late for BRCA testing to matter

  • BRCA testing is useful whenever the result could change management for the woman or her relatives — a woman in her forties with breast cancer, a strong family history, or a family deciding on preventive surgery can all benefit.
  • Testing access in India has improved through academic centres and private labs. The bigger barrier is awareness, not impossibility. Dismissing testing because a woman is already married, already has children, or is not in a metro is poor practice.
  • A positive result can change surveillance, surgery timing, and family (cascade) testing. Saying it is 'too late' usually reflects missed counselling, not a genuine lack of value.

Frequently asked questions

Do I have to remove my ovaries if I am having a hysterectomy?

No. Removing the uterus and removing the ovaries are separate decisions. If you are premenopausal, average-risk, and your ovaries are healthy, keeping them is usually preferred to avoid sudden surgical menopause. Ask your surgeon directly why ovary removal is being proposed, and whether removing only the fallopian tubes (salpingectomy) is an option.

What is the difference between surgical menopause and natural menopause?

Natural menopause unfolds over years of gradually falling hormones. Surgical menopause from removing both ovaries is abrupt — hormones drop the same day. Symptoms such as hot flashes, sleep disruption, and mood changes often start immediately and can feel more intense, which is why a hormone plan is usually arranged in advance.

Is HRT safe after my ovaries are removed before menopause?

For most women without a contraindication such as oestrogen-sensitive breast cancer, HRT until about age 50 is not just safe to consider — it is usually recommended to protect bones, heart health, sleep, and quality of life. If your uterus is still present, oestrogen is combined with a progestogen; if it has been removed, oestrogen alone is often used. Discuss this before surgery, not after symptoms begin.

Can I still have a normal sex life after oophorectomy?

Yes, though it may take some support. Lower oestrogen can cause vaginal dryness, reduced desire, and discomfort. Many women improve with HRT, local vaginal oestrogen, lubricants and moisturisers, pelvic-floor care, and open communication with their partner. If symptoms persist, a menopause specialist or counsellor can help.

When should a BRCA carrier have risk-reducing surgery?

Timing is guided by the mutation: roughly age 35 to 40 for BRCA1 and 40 to 45 for BRCA2, once childbearing is complete. The aim is to act before ovarian cancer risk rises sharply. This should happen within a structured pathway including genetic counselling, fertility planning, and an HRT discussion for premenopausal women.

Sources